645 related articles for article (PubMed ID: 19060529)
1. Evidence for immunosuppression in lung transplantation.
Hopkins PM; McNeil K
Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
[TBL] [Abstract][Full Text] [Related]
2. New advances in antirejection therapy.
Chan M; Pearson GJ
Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
[TBL] [Abstract][Full Text] [Related]
3. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
4. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression: what's standard and what's new?
Witt CA; Hachem RR
Semin Respir Crit Care Med; 2013 Jun; 34(3):405-13. PubMed ID: 23821513
[TBL] [Abstract][Full Text] [Related]
6. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?
Rostaing L; Kamar N
J Nephrol; 2010; 23(2):133-42. PubMed ID: 20155724
[TBL] [Abstract][Full Text] [Related]
7. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
8. Current immunosuppressive approaches in liver transplantation.
Iacob S; Cicinnati VR; Beckebaum S
Panminerva Med; 2009 Dec; 51(4):215-25. PubMed ID: 20195232
[TBL] [Abstract][Full Text] [Related]
9. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
[TBL] [Abstract][Full Text] [Related]
10. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
[TBL] [Abstract][Full Text] [Related]
11. Out with the old, in with the new: immunosuppression minimization in children.
Sarwal MM
Curr Opin Organ Transplant; 2008 Oct; 13(5):513-21. PubMed ID: 19060535
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy in lung transplantation: state of the art.
Korom S; Boehler A; Weder W
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1045-55. PubMed ID: 19349186
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive agents in organ transplantation: past, present, and future.
Hong JC; Kahan BD
Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression for lung transplantation: evidence to date.
Snell GI; Westall GP
Drugs; 2007; 67(11):1531-9. PubMed ID: 17661526
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression for heart transplantation: where are we now?
Kobashigawa JA; Patel JK
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):203-12. PubMed ID: 16568129
[TBL] [Abstract][Full Text] [Related]
16. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
17. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
18. Proliferation signal inhibitors and cardiac allograft vasculopathy.
Raichlin E; Kushwaha SS
Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
[TBL] [Abstract][Full Text] [Related]
19. The impact of mTOR inhibitors on the development of malignancy.
Geissler EK
Transplant Proc; 2008 Dec; 40(10 Suppl):S32-5. PubMed ID: 19100904
[TBL] [Abstract][Full Text] [Related]
20. Minimization of immunosuppression in kidney transplantation.
Augustine JJ; Hricik DE
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
